Synovics Pharmaceuticals, Inc. (SYVC)

Synovics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Oct 10, 2025	Oct 31, 2008	Oct 31, 2007	Oct 31, 2006	Oct 31, 2005	Oct 31, 2004
Market Capitalization	0	9	24	52	52	3
Market Cap Growth	-99.80%	-61.97%	-54.36%	0.20%	1544.79%	190.45%
Enterprise Value	-	18	42	66	54	5
Last Close Price	0.00	0.35	0.80	2.00	2.30	0.20
PS Ratio	0.00	0.35	1.01	4.95	6345.70	32.00
PB Ratio	0.00	1.81	-2.93	3.98	4.60	-3.49
P/FCF Ratio	0.00	2.87	-	-	-	-
P/OCF Ratio	0.00	2.34	-	-	-	-
EV/Sales Ratio	-	0.70	1.80	6.29	6610.76	54.28
EV/FCF Ratio	-	5.76	-	-	-	-
Debt / Equity Ratio	-7.95	1.31	-2.32	1.36	0.25	-1.64
Debt / FCF Ratio	3.46	2.08	-	-	-	-
Asset Turnover	0.90	1.14	0.75	0.38	0.00	0.04
Inventory Turnover	6.48	7.04	7.82	6.86	1.70	0.48
Quick Ratio	0.10	0.29	0.13	0.34	0.02	0.17
Current Ratio	0.27	0.53	0.22	0.59	0.05	0.19
Return on Equity (ROE)	-314.28%	-	-834.42%	-61.69%	-51.75%	-
Return on Assets (ROA)	-12.75%	-6.80%	-20.62%	-8.11%	-12.08%	-19.33%
Return on Capital Employed (ROCE)	-354.10%	-28.10%	609.40%	-14.00%	-16.90%	86.90%
Earnings Yield	-138235.98%	-44.31%	-87.74%	-16.45%	-5.60%	-35.57%
FCF Yield	48624.58%	34.89%	-13.12%	-10.78%	-4.80%	-20.37%
Buyback Yield / Dilution	-84.15%	-23.47%	26.78%	-29.61%	-156.30%	-80.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.